# About Reviews CJC-1295: An Editorial Literature Review

> Reviews CJC-1295 is an independent editorial project summarizing the peer-reviewed CJC-1295 research literature. Not a clinic, not a vendor, not a prescriber. What 'reviews' means here.

An independent editorial project that reads the published record in sequence. No clinic, no counter, no prescription.

## What Reviews CJC-1295 Is

Reviews CJC-1295 is an independent editorial project that publishes summaries of the peer-reviewed research literature on CJC-1295. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site is built as a literature review in the literal sense: it reads the published record in the order the evidence accrued — the 2005 rat albumin-bioconjugate proof, the 2006 human pharmacokinetic studies, the 2009 proteomic biomarkers, the 2010 black-market identification, and the 2021-2025 detection methods — and presents what each study measured, with the source attached.

## What 'Reviews' Means Here

The word 'reviews' in this site's name is editorial framing, not a service offering. It describes the position the publisher occupies relative to the literature — a reviewer of published studies — not a claim that the site reviews products, vendors, or treatments for purchase, and not a claim that it offers consultation. There is no storefront here and no recommendation to obtain CJC-1295 from anyone.

We summarize what the studies found. We do not rank suppliers, we do not link to sellers, and we do not tell any reader what to do. Where the evidence is strong — the multi-day half-life, the preserved GH pulsatility — we say so plainly. Where it is absent — long-term human safety, controlled efficacy in healthy adults — we mark the gap just as plainly [12].

## Editorial Standards

Every quantitative claim on this site is tied to a specific citation in the [full reference list](/references), drawn from PubMed-indexed journals, ClinicalTrials.gov, and primary regulatory materials. We describe doses as administered to a named species by a named route in a named study — never as a recommendation for any person. We do not use competitor brand names. CJC-1295 is not approved for human use and is prohibited at all times in tested sport [4]; we state that wherever it is relevant rather than burying it. When the literature is updated, this review is updated.

---

A scroll-told review of the CJC-1295 literature, read top to bottom in the order the evidence accrued — the DAC and no-DAC tracks kept apart, every figure logged to its study and the human gaps left visibly open; no clinic behind the rail and nothing here dispensed or for sale.